Generic Available:
Yes
Use:
Treatment of hypochloremic states or metabolic alkalosis
Pregnancy Risk Factor:
C
Pregnancy Implications:
Reproduction studies have not been conducted.
Contraindications:
Severe hepatic or renal dysfunction
Warnings/Precautions:
Use caution in patients with primary respiratory acidosis or pulmonary insufficiency. Safety and efficacy have not been established in children.
Adverse Reactions:
Frequency not defined.
Central nervous system: Headache, coma, drowsiness, EEG abnormalities, mental confusion, seizure
Dermatologic: Rash
Endocrine & metabolic: Calcium-deficient tetany, hyperchloremia, hypokalemia, metabolic acidosis, potassium and sodium may be decreased
Gastrointestinal: Abdominal pain, gastric irritation, nausea, vomiting
Hepatic: Ammonia may be increased
Local: Pain at site of injection
Neuromuscular & skeletal: Twitching
Respiratory: Hyperventilation
Overdosage/Toxicology:
Symptoms of overdose include abdominal pain, apnea, bradycardia, confusion, coma, diuresis, headache, hyperchloremic hypokalemic metabolic acidosis, hyperventilation, hypomagnesemia, hypovolemia, nausea, pulmonary edema, seizures, vomiting. Administer electrolytes as indicated.
Stability:
Prior to use, vials should be stored at controlled room temperature of 15°C to 30°C (59°F to 86°F). Solution may crystallize if exposed to low temperatures. If crystals are observed, warm vial to room temperature in a water bath prior to use. Dilute prior to use; final concentration should not exceed 1% to 2% ammonium chloride. Suggested dilution: Mix contents of 1-2 vials (100-200 mEq) in 500-1000 mL NS.
Compatibility:
Stable in dextran 6% in D5W, dextran 6% in NS, D5LR, D5NS, D5
1/2NS, D5
1/4NS, D5W, D10W, LR,
1/2NS, NS
Y-site administration: Variable (consult detailed reference): Warfarin
Compatibility when admixed: Incompatible: Levorphanol. Variable (consult detailed reference): Dimenhydrinate, potassium chloride
Mechanism of Action:
Increases acidity by increasing free hydrogen ion concentration
Pharmacodynamics/Kinetics:
Metabolism: Hepatic; forms urea and hydrochloric acid
Excretion: Urine
Dosage:
Metabolic alkalosis: The following equations represent different methods of correction utilizing either the serum HCO3
-, the serum chloride, or the base excess
Dosing of mEq NH4Cl via the chloride-deficit method (hypochloremia):
Dose of mEq NH4Cl = [0.2 L/kg x body weight (kg)] x [103 - observed serum chloride]; administer 50% of dose over 12 hours, then re-evaluate
Note: 0.2 L/kg is the estimated chloride volume of distribution and 103 is the average normal serum chloride concentration (mEq/L)
Dosing of mEq NH4Cl via the bicarbonate-excess method (refractory hypochloremic metabolic alkalosis):
Dose of NH4Cl = [0.5 L/kg x body weight (kg)] x (observed serum HCO3- - 24); administer 50% of dose over 12 hours, then re-evaluate
Note: 0.5 L/kg is the estimated bicarbonate volume of distribution and 24 is the average normal serum bicarbonate concentration (mEq/L)
These equations will yield different requirements of ammonium chloride
Administration:
Administer by slow intravenous infusion to avoid local irritation and adverse effects. Rate of infusion should not exceed 5 mL/minute in an adult.
Monitoring Parameters:
Serum bicarbonate; signs and symptoms of ammonia toxicity
Dental Health: Effects on Dental Treatment:
No significant effects or complications reported
Dental Health: Vasoconstrictor/Local Anesthetic Precautions:
No information available to require special precautions
Mental Health: Effects on Mental Status:
May cause sedation and confusion
Mental Health: Effects on Psychiatric Treatment:
None reported
Dosage Forms:
Injection, solution: Ammonium 5 mEq/mL and chloride 5 mEq/mL (20 mL) [equivalent to ammonium chloride 267.5 mg/mL]
References
Martin WJ and Matzke GR, "Treating Severe Metabolic Alkalosis,"Clin Pharm, 1982, 1(1):42-8.
Megarbane B, Bruneel F, Bedos JP, et al, "Ammonium Chloride Poisoning: A Misunderstood Cause of Metabolic Acidosis With Normal Anion Gap,"Intensive Care Med, 2000, 26(12):1869.